Nasopharyngeal Cancer - Symptoms, Causes, Treatment & Prevention

Overview

Nasopharyngeal cancer (NPC) is a malignant tumor that arises from the epithelial cells that line the nasopharynx – the upper part of the throat behind the nose and above the soft palate. Unlike most head‑and‑neck cancers, NPC is closely linked to viral infection (Epstein‑Barr virus, EBV) and to certain dietary and genetic factors.

Who it affects

• Geographic prevalence: Highest incidence in Southern China, Hong Kong, Macau, Taiwan, Southeast Asia, and parts of the Arctic. In the United States, NPC accounts for <1 % of all cancers.
• Age: Most cases are diagnosed between 40 and 60 years, but it can occur at any age.
• Sex: Men are about 2–3 times more likely to develop NPC than women.
• Ethnicity: People of Chinese, Southeast Asian, North African, and Inuit ancestry have higher rates.

According to the American Cancer Society, about 2,200 new cases of NPC are expected in the United States in 2026, with an estimated 800 deaths. Worldwide, the International Agency for Research on Cancer (IARC) reports roughly 130,000 new cases and 80,000 deaths each year.

Symptoms

Because the nasopharynx is hidden deep behind the nose, early disease may cause only subtle or no symptoms. When symptoms appear, they can be mistaken for a sinus infection or ear problem. Below is a comprehensive list, grouped by system.

Ear‑related symptoms

• Unilateral (one‑sided) hearing loss – often gradual.
• Ear fullness or a feeling of “blocked” ear.
• Repeated middle‑ear infections (otitis media) or fluid behind the eardrum.
• Tinnitus – ringing or buzzing in the ear.

Nasal and sinus symptoms

• Persistent nasal congestion, especially on one side.
• Rhinorrhea (runny nose) that may be bloody or thick.
• Facial pain or pressure around the nose and cheeks.
• Decreased sense of smell (anosmia) or altered taste.

Throat and mouth symptoms

• Difficulty swallowing (dysphagia) or a sensation of a lump in the throat.
• Chronic sore throat that does not improve with typical treatment.
• Unexplained mouth or throat pain, especially at night.
• Persistent hoarseness or voice changes.

Neck and lymph‑node symptoms

• Enlarged, painless lymph nodes in the neck (often the first sign).
• Swelling or a visible lump near the jawline.

Systemic symptoms

• Unexplained weight loss.
• Fatigue or malaise.
• Fever, night sweats, or generalized bone pain (in advanced disease).

Important note: Any persistent, unexplained symptom lasting more than 4–6 weeks—especially unilateral ear or neck changes—should be evaluated by a health professional.

Causes and Risk Factors

Nasopharyngeal cancer is multifactorial. No single cause explains all cases, but the following factors have strong epidemiologic support.

Epstein‑Barr virus (EBV) infection

EBV is present in >95 % of NPC tumor cells worldwide. The virus integrates into the DNA of nasopharyngeal epithelial cells, promoting malignant transformation. Serologic testing for EBV antibodies (e.g., VCA‑IgA, EA‑IgA) is often used in screening high‑risk populations.

Genetic susceptibility

• Family history of NPC increases risk 2–4 fold.
• Specific HLA (human leukocyte antigen) genotypes—particularly HLA‑A2, HLA‑B46—are associated with higher susceptibility.

Dietary factors

• Frequent consumption of salted fish, especially Cantonese-style pickled fish, which contains nitrosamines (potent carcinogens).
• Preserved or smoked meats, and foods high in nitrosamine content.
• Low intake of fresh fruits and vegetables, which reduces protective antioxidants.

Environmental exposures

• Wood dust, formaldehyde, and certain occupational chemicals.
• Second‑hand smoke and active tobacco use (though smoking is a weaker risk factor than for other head‑and‑neck cancers).

Other factors

• Chronic inflammation of the nasopharynx (e.g., from allergies or chronic sinusitis).
• Immunosuppression, such as HIV infection or organ transplantation.

Diagnosis

Diagnosis of NPC involves a combination of clinical evaluation, imaging, endoscopic examination, and tissue biopsy.

Initial clinical assessment

• Detailed history focusing on duration and laterality of symptoms, dietary habits, family history, and EBV exposure.
• Physical exam of the ear, nose, throat, and neck, paying special attention to enlarged lymph nodes.

Endoscopic examination

A flexible nasopharyngoscope (a thin, lighted tube) is inserted through the nose to directly visualize the nasopharynx. Abnormal mucosal thickening, ulcerations, or mass lesions can be seen and biopsied.

Imaging studies

• Magnetic Resonance Imaging (MRI) – preferred for soft‑tissue detail, evaluating skull‑base invasion, and delineating tumor extent.
• Computed Tomography (CT) scan – useful for assessing bone involvement and for radiotherapy planning.
• Positron Emission Tomography (PET‑CT) – detects distant metastases and evaluates metabolic activity of the primary lesion.

Biopsy and pathology

Endoscopic or image‑guided core needle biopsy provides tissue for histopathologic diagnosis. NPC is classified by the WHO into three main types:

1. Keratinizing squamous cell carcinoma (rare in endemic areas).
2. Non‑keratinizing differentiated carcinoma (most common).
3. Undifferentiated (lymphoepithelial) carcinoma – strongly associated with EBV.

Laboratory tests

• EBV DNA quantitative PCR in plasma – useful for baseline staging and monitoring treatment response.
• Complete blood count, liver and renal function tests – baseline before chemotherapy or radiotherapy.

Staging

Staging follows the AJCC (American Joint Committee on Cancer) 8th edition, ranging from Stage I (localized disease) to Stage IV (advanced, with distant metastasis). Accurate staging guides treatment planning.

Treatment Options

Treatment is multidisciplinary, involving radiation oncologists, medical oncologists, head‑and‑neck surgeons, and supportive‑care teams. The mainstay is radiation, often combined with chemotherapy.

Radiation therapy

• Intensity‑Modulated Radiation Therapy (IMRT) – the current gold standard; delivers high doses conforming to tumor shape while sparing surrounding tissue.
• Proton therapy – available at specialized centers; may further reduce dose to critical structures such as the brain stem.
• Doses typically range from 66–70 Gy for the primary tumor and 50–60 Gy for involved neck nodes.

Chemotherapy

• Concurrent chemoradiation (cisplatin 100 mg/m² every 3 weeks or weekly low‑dose cisplatin) is standard for locally advanced disease (Stage III–IV).
• Induction (neoadjuvant) chemotherapy – often a 3‑drug regimen (docetaxel, cisplatin, 5‑fluorouracil, “TPF”) given before radiation to shrink large tumors.
• Adjuvant (post‑radiation) chemotherapy may be considered for high‑risk pathological features.

Surgery

Surgery plays a limited role because of the deep location. It is considered for:

• Recurrent disease after definitive radiation.
• Residual neck disease not responding to chemoradiation.
• Rare early-stage tumors amenable to endoscopic resection.

Targeted and immunotherapy

• PD‑1 inhibitors (e.g., pembrolizumab, nivolumab) – FDA‑approved for recurrent/metastatic NPC after platinum‑based chemotherapy failure.
• Research on EBV‑directed vaccines and adoptive T‑cell therapy is ongoing.

Supportive care & lifestyle adjustments

• Nutrition counseling – high‑calorie, high‑protein diet to counter weight loss.
• Speech and swallowing therapy – especially after radiation to the nasopharynx.
• Pain management, oral care, and management of xerostomia (dry mouth) with saliva substitutes.
• Psychosocial support – counseling, support groups, and mental‑health services.

Living with Nasopharyngeal Cancer

Living with NPC involves managing side effects, maintaining nutrition, and monitoring for recurrence.

Practical daily‑management tips

• Nutrition: Eat small, frequent meals; choose soft or pureed foods if swallowing is painful. Add protein shakes if oral intake is inadequate.
• Oral hygiene: Brush teeth gently after meals, use fluoride toothpaste, and rinse with saline or alcohol‑free mouthwash to lower infection risk.
• Hydration: Aim for at least 2 L of fluid daily; sip water throughout the day to lessen dry mouth.
• Exercise: Light aerobic activity (walking, tai chi) improves fatigue and maintains muscle mass.
• Smoking & alcohol: Stop smoking and limit alcohol – both can impair healing and increase secondary cancer risk.
• Follow‑up schedule: Typically every 3 months for the first 2 years, then every 6 months up to 5 years, and annually thereafter. Visits include physical exam, nasopharyngoscopy, imaging, and EBV DNA testing.
• Emotional health: Seek counseling, join cancer survivor groups, and practice stress‑reduction techniques (mindfulness, yoga).

Managing treatment side effects

Side effect	Common management strategies
Xerostomia (dry mouth)	Saliva substitutes, pilocarpine, sipping water, sugar‑free gum.
Skin irritation from radiation	Gentle cleansing, moisturizers without fragrance, avoiding sun exposure.
Cisplatin‑induced nausea	Antiemetics (ondansetron), dietary adjustments, hydration.
Hearing loss	Baseline audiogram, hearing aids if needed, avoid ototoxic meds.
Swallowing difficulties	Speech‑language pathology, thickened liquids, modified diet textures.

Prevention

Because many risk factors are non‑modifiable (e.g., genetics, EBV exposure), prevention focuses on lifestyle and early detection.

• Dietary modifications: Reduce intake of salted, smoked, or cured fish/meat; increase fresh fruits, vegetables, and foods rich in antioxidants.
• Vaccination & infection control: No EBV vaccine is available yet, but good hygiene and avoiding intimate contact with individuals with active EBV infection may lower viral load.
• Tobacco & alcohol cessation: Quit smoking and limit alcohol to ≤1 drink per day for women, ≤2 for men.
• Screening in high‑risk populations: Serial measurement of plasma EBV DNA, especially in endemic regions or among families with a history of NPC.
• Occupational safety: Use protective equipment when exposed to wood dust, formaldehyde, or other known carcinogens.

Complications

If left untreated or inadequately controlled, NPC can lead to serious complications.

• Local invasion: Tumor can erode the skull base, causing cranial nerve palsies (diplopia, facial weakness), or invade the orbit leading to vision loss.
• Metastasis: Common sites include bone, lung, liver, and distant lymph nodes.
• Obstructive complications: Blockage of the eustachian tube → chronic otitis media, hearing loss, or middle‑ear effusion.
• Airway compromise: Large tumors may obstruct the nasopharyngeal airway causing breathing difficulty, especially when supine.
• Secondary cancers: Radiation may increase the risk of thyroid, brain, or other head‑and‑neck malignancies years later.
• Psychological impact: Depression, anxiety, and social isolation are common and require attention.

When to Seek Emergency Care

---

References: Mayo Clinic, CDC, National Cancer Institute, World Health Organization, American Cancer Society, International Agency for Research on Cancer, Cleveland Clinic, peer‑reviewed journals (e.g., J Clin Oncol, Int J Cancer), and guideline statements from NCCN (2024). All information reflects knowledge available as of April 2026.